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José Vassallo1,2It is my great pleasure and honor to announce that Applied
Cancer Research entered a new phase and published its
first articles in partnership with BioMed Central. Founded
in 1975 as Acta Oncologica Brasileira and renamed in
2004 to its current title, the journal has always focused on
clinical, surgical and translational research in the field of
oncology and values multidisciplinary approaches.
Applied Cancer Research is the official journal of A.C.
Camargo Cancer Center, one of the largest cancer hospital
in Brazil. Founded in 1953 in São Paulo – the 4th largest
city in the world – A.C. Camargo Cancer Center is also a
distinguished research and education center in oncology
and has partnerships with institutions such as MD
Anderson Cancer Center and the International Agency for
Research on Cancer.
The growing scientific output, as well as the excellence
in patient care that A.C. Camargo Cancer Center has
accomplished over the past years, have led the Center to
the decision of internationalizing the journal. BioMed
Central has been chosen for its pioneering experience in
open access publishing in medicine and health sciences.
As a multidisciplinary journal, Applied Cancer Research
considers for publication original manuscripts addressing
genetics, genomics, pathology, diagnosis, treatment, pa-
tient care, and epidemiology. I invite you to submit
original research and reviews as well as well exceptionally
documented and educative case reports.
The journal editorial board comprises me as Editor-in-
Chief, six Associate Editors, and an international group
of 47 experts in the field of oncology [1]. All manu-
scripts submitted to Applied Cancer Research will be
peer-reviewed by one editor and at least two reviewers.
The journal is a member of, and subscribes to the prin-
ciples of the Committee on Publication Ethics (COPE), a
forum for editors and publishers to discuss all aspects ofCorrespondence: vassallomeister@gmail.com
1A.C. Camargo Cancer Center, São Paulo, Brazil
2University of Campinas, Campinas, São Paulo, Brazil
© The Author(s). 2016 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zepublication ethics. As a COPE member, we are expected
to follow the Code of Conduct for Journal Editors [2].
Benefits to authors
The partnership with BioMed Central is expected to
increase international visibility of the articles published
in the journal. Authors should note that, under the CC-
BY license, they retain the copyright of their work and
any third party is allowed to use, reproduce, and
disseminate the author’s original work, as long as
credits are given. The publication costs are currently
covered by the A.C. Camargo Cancer Center, so authors
do not need to pay an article-processing charge for
each article accepted for publication.
We realize how important indexing databases such as
PubMed, Web of Science and Scopus are important to
authors and our team is highly engaged and working hard
to have the journal submitted to those services in the near
future, as the journal develops to meet their selective
criteria. Applied Cancer Research is already indexed in LI-
LACS, the most comprehensive index scientific and tech-
nical literature of Latin America and the Caribbean.
Despite the highly competitive publishing scenario,
our conviction is that Applied Cancer Research can
make a difference and offer quality content for the on-
cology community.
I would like to thank A.C. Camargo Cancer Center
and our Editorial Board Members for their valuable
support. I kindly invite you to keep up to date with the
latest articles and welcome your submissions.
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